Citations 1
IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers
Vandergaast, Rianna , Reiter, Samantha , Lathrum, Chase , Lech, Patrycja, Gnanadurai, Clement W., Haselton, Michelle, Buehler, Jason , Narjari, Riya , Schnebeck, Luke, Roesler, Anne, Sevola, Kara , Suksanpaisan, Lukkana , Bexon, Alice, Naik, Shruthi , Brunton, Bethany, Rafael, Grace, Tran, Sheryl, Baum, Alina , Kyratsous, Christos A. , Peng, Kah Whye, Russell, Stephen J. , Russell, Stephen J , Vandergaast, Rianna , Carey, Timothy S. , Weaver, Scott C
mSphere | June 10, 2021 | Volume: 6 | Issue: 3 | Pages: No page available
Since its emergence at the end of 2019, SARS-CoV-2, the causative agent of COVID-19, has caused over 100 million infections and 2.4 million deaths worldwide. Recently, countries have begun administering approved COVID-19 vaccines, which elicit strong immune responses and prevent disease in most vaccinated individuals.